MK-0533

CAS No. 668455-28-5

MK-0533( —— )

Catalog No. M36129 CAS No. 668455-28-5

MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 237 Get Quote
5MG 366 Get Quote
10MG 543 Get Quote
25MG 845 Get Quote
50MG 1150 Get Quote
100MG 1521 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-0533
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    668455-28-5
  • Formula Weight
    527.49
  • Molecular Formula
    C28H24F3NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1N(C=2C(C1C(=O)C3=CC=C(OC)C=C3)=CC=C(OC(F)(F)F)C2)C4=CC(O[C@@H](C(O)=O)CC)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fenofibrate

    A PPARα agonist that exhibits EC50 of 18 and 30 uM for murine and human PPARα, respectively.

  • CUDA

    CUDA is an effective soluble cyclohydrolase inhibitor with IC50 of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively.

  • Troglitazone

    A PPARγ activator that has antidiabetic, anti-tumor and anti-inflammatory activities.